A*Star Avatamed, A*STAR Launch Joint Precision Oncology Lab in Singapore Together with Singapore's Agency for Science, Technology, and Research, Avatamed will offer its drug screening platform to oncologists and drugmakers. Singapore Precision Medicine Program to Analyze Genetics of 150K Citizens The program is part of a 10-year initiative focused on establishing the frameworks and infrastructure to roll out precision medicine throughout the country. Lucence, Waseda University Partner to Develop Laser-Based Liquid Biopsy Platform The partners believe the platform, which captures high resolution images of CTCs and clusters, has potential applications in early cancer detection and disease monitoring. Spatial Omics Firms Use AGBT as Launchpad for New Tech Premium Vizgen, Rebus Biosystems, and Veranome Biosystems described their FISH-based platforms for spatial gene expression analysis for the first time. MiRxes Receives CE Mark, Singapore Regulatory Approval for Multiplex SARS-CoV-2, Flu Test The kit was jointly developed by Singapore's Agency for Science, Technology, and Research, Tan Tock Seng Hospital, and MiRxes. Nov 4, 2020 Singapore's MiRxes Sets Out to Sell Gastric Cancer Test Across Asia Premium Aug 12, 2020 ImmunoScape Using $11M Funding Round to Establish US Operations Premium Aug 12, 2020 ImmunoScape Raises $11M to Support Development of Immune Profiling Platform Aug 10, 2020 Singapore's Avatamed Raises $1M in Seed Funding Mar 27, 2020 10x Genomics Joins Single-Cell Multi-Omics Alliance to Develop Antibody Therapies for Coronavirus Mar 16, 2020 Chan Zuckerberg Initiative Awards $400K in Funding for Asian Immune Cell Atlas Project Mar 3, 2020 Singapore Clears New SARS-CoV-2 Assay for Clinical Use Feb 3, 2020 Lung Adenocarcinoma Genomic Features Differ in East Asians, Europeans Oct 17, 2019 Three Asian Populations Sequenced for Singapore 10K Genome Project Sep 19, 2019 Inex Innovate to Launch New Molecular Tests for Ovarian Cancer, Breast Cancer in Asia Premium Sep 10, 2019 Biolidics, A*STAR Genome Institute of Singapore to Develop Liquid Biopsy Breast Cancer Test Jul 10, 2019 One BioMed Raises $5M in Series A Round Dec 18, 2018 Indivumed, A*STAR Collaborate on Asian-Centric Cancer Database for Personalized Oncology Dec 6, 2018 Cancer Early Detection Firm Ark Launches With $40M Series A Investment Jul 3, 2018 Indivumed Partners With A*STAR to Build Out Cancer Database May 22, 2018 Recessive Mutation May Cause New Neurodevelopmental Disorder Dec 14, 2017 Inex Innovations Exchange Developing Fetal Cell-Based NIPT to Expand Test Portfolio Premium Nov 21, 2017 MiRxes Rolls out Gastric Cancer qPCR Dx in Europe; Expands Operations to US, Asia Premium Nov 20, 2017 Inex Innovations Licenses NIPT Technology From A*STAR Jul 10, 2017 Biocartis, Exploit Technologies Ink MDx Assay Development Deal Load More Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.